Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000628694 | SCV000749600 | likely benign | Bloom syndrome | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001019091 | SCV001180405 | likely benign | Hereditary cancer-predisposing syndrome | 2018-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001019091 | SCV002530072 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-07 | criteria provided, single submitter | curation | |
Natera, |
RCV000628694 | SCV002090525 | likely benign | Bloom syndrome | 2020-10-13 | no assertion criteria provided | clinical testing |